Francine Kaufman

19.8k total citations · 5 hit papers
190 papers, 12.6k citations indexed

About

Francine Kaufman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Francine Kaufman has authored 190 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Endocrinology, Diabetes and Metabolism, 69 papers in Surgery and 61 papers in Genetics. Recurrent topics in Francine Kaufman's work include Diabetes Management and Research (101 papers), Pancreatic function and diabetes (61 papers) and Diabetes and associated disorders (55 papers). Francine Kaufman is often cited by papers focused on Diabetes Management and Research (101 papers), Pancreatic function and diabetes (61 papers) and Diabetes and associated disorders (55 papers). Francine Kaufman collaborates with scholars based in United States, Ireland and United Kingdom. Francine Kaufman's co-authors include Sonia Caprio, Martin Silink, Jonathan E. Shaw, Paul Zimmet, Peter H. Bennett, Gary Wong, Naoko Tajima, Mary Halvorson, Silva Arslanian and K. G. M. M. Alberti and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Francine Kaufman

183 papers receiving 11.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The metabolic syndrome in children and adolescents ? an IDF consensus report

2007 1.5k citations Paul Zimmet, K. G. M. M. Alberti et al. Pediatric Diabetes profile →
Care of Children and Adolescents With Type 1 Diabetes

2005 989 citations Janet Silverstein, Francine Kaufman et al. Diabetes Care profile →
The metabolic syndrome in children and adolescents

2007 734 citations Paul Zimmet, Francine Kaufman et al. profile →
Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia

2013 428 citations Richard M. Bergenstal, David C. Klonoff et al. New England Journal of Medicine profile →
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

2017 415 citations Satish K. Garg, Bruce A. Buckingham et al. Diabetes Technology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francine Kaufman United States	52	7.0k	3.8k	3.7k	2.8k	1.9k	190	12.6k
Antoinette Moran United States	63	4.4k 0.6×	3.0k 0.8×	4.0k 1.1×	2.0k 0.7×	1.3k 0.7×	182	12.5k
Janet Silverstein United States	52	4.8k 0.7×	2.8k 0.8×	2.4k 0.6×	2.0k 0.7×	1.4k 0.7×	181	9.8k
Catherine Pihoker United States	53	7.2k 1.0×	5.2k 1.4×	3.6k 1.0×	1.2k 0.4×	1.4k 0.7×	214	11.3k
Philip Zeitler United States	48	4.7k 0.7×	2.5k 0.7×	2.0k 0.5×	1.7k 0.6×	1.1k 0.6×	173	8.7k
Moshe Phillip Israel	59	6.9k 1.0×	4.1k 1.1×	3.8k 1.0×	1.1k 0.4×	1.5k 0.8×	363	12.5k
Johnny Ludvigsson Sweden	63	7.6k 1.1×	8.6k 2.3×	6.6k 1.8×	1.5k 0.5×	1.1k 0.5×	545	16.2k
Elizabeth A. Davis Australia	53	5.2k 0.7×	3.0k 0.8×	3.7k 1.0×	1.5k 0.5×	679 0.3×	279	9.2k
Reinhard W. Holl Germany	72	12.1k 1.7×	8.0k 2.1×	6.3k 1.7×	1.7k 0.6×	1.3k 0.7×	648	18.6k
Denis Daneman Canada	55	6.1k 0.9×	3.3k 0.9×	2.5k 0.7×	777 0.3×	1.2k 0.6×	232	9.8k
Claude Marcus Sweden	56	2.4k 0.4×	1.7k 0.4×	2.0k 0.5×	3.1k 1.1×	981 0.5×	273	9.7k

Countries citing papers authored by Francine Kaufman

Since Specialization

Citations

This map shows the geographic impact of Francine Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francine Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francine Kaufman more than expected).

Fields of papers citing papers by Francine Kaufman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francine Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francine Kaufman. The network helps show where Francine Kaufman may publish in the future.

Co-authorship network of co-authors of Francine Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of Francine Kaufman. A scholar is included among the top collaborators of Francine Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francine Kaufman. Francine Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bailey, Timothy S., David R. Liljenquist, Douglas Denham, et al.. (2025). Evaluation of Accuracy and Safety of the 365-Day Implantable Eversense Continuous Glucose Monitoring System: The ENHANCE Study. Diabetes Technology & Therapeutics. 27(5). 407–411. 2 indexed citations

Wood, Michael A., Dorothy I. Shulman, Gregory P. Forlenza, et al.. (2018). In-Clinic Evaluation of the MiniMed 670G System “Suspend Before Low” Feature in Children with Type 1 Diabetes. Diabetes Technology & Therapeutics. 20(11). 731–737. 18 indexed citations

Stone, Michael P., Pratik Agrawal, Xiaoxiao Chen, et al.. (2018). Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch. Diabetes Technology & Therapeutics. 20(10). 689–692. 86 indexed citations

Forlenza, Gregory P., Orit Pinhas‐Hamiel, David R. Liljenquist, et al.. (2018). Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(1). 11–19. 138 indexed citations

Maahs, David M., H. Peter Chase, Emily Westfall, et al.. (2014). The Effects of Lowering Nighttime and Breakfast Glucose Levels with Sensor-Augmented Pump Therapy on Hemoglobin A1c Levels in Type 1 Diabetes. Diabetes Technology & Therapeutics. 16(5). 284–291. 9 indexed citations

Bergenstal, Richard M., David C. Klonoff, Satish K. Garg, et al.. (2013). Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia. New England Journal of Medicine. 369(3). 224–232. 428 indexed citations breakdown →

Willi, Steven M., Kathryn Hirst, Russell Jago, et al.. (2012). Cardiovascular risk factors in multi‐ethnic middle school students: the HEALTHY primary prevention trial. Pediatric Obesity. 7(3). 230–239. 34 indexed citations

Kaufman, Francine, Kathryn Hirst, John B. Buse, et al.. (2011). Effect of Secular Trends on a Primary Prevention Trial: The HEALTHY Study Experience. Childhood Obesity. 7(4). 291–297. 7 indexed citations

Mittelman, Steven D., et al.. (2007). Relationship of highly sensitive C-reactive protein and lipid levels in adolescents with type 1 diabetes mellitus. Pediatric Diabetes. 9(2). 122–126. 5 indexed citations

10.

Peterson, Kevin, et al.. (2007). Management of type 2 diabetes in youth: an update.. PubMed. 76(5). 658–64. 19 indexed citations

11.

Zimmet, Paul, K. G. M. M. Alberti, Francine Kaufman, et al.. (2007). The metabolic syndrome in children and adolescents ? an IDF consensus report. Pediatric Diabetes. 8(5). 299–306. 1547 indexed citations breakdown →

12.

Dreimane, Daina, et al.. (2006). Feasibility of a hospital-based, family-centered intervention to reduce weight gain in overweight children and adolescents. Diabetes Research and Clinical Practice. 75(2). 159–168. 35 indexed citations

13.

Pitukcheewanont, Pisit, et al.. (2002). Resumption of Growth after Methionyl-Free Human Growth Hormone Therapy in a Patient with Neutralizing Antibodies to Methionyl Human Growth Hormone. Journal of Pediatric Endocrinology and Metabolism. 15(5). 653–7. 3 indexed citations

14.

Sayre, James, et al.. (2000). Early Identification of Children Predisposed to Low Peak Bone Mass and Osteoporosis Later in Life¹. The Journal of Clinical Endocrinology & Metabolism. 85(10). 3908–3918. 108 indexed citations

15.

Kaufman, Francine, et al.. (2000). Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes.. Diabetes Care. 23(5). 579–582. 51 indexed citations

16.

Kaufman, Francine, et al.. (1999). Insulin pump therapy in Type 1 pediatric patients: now and into the year 2000. Diabetes/Metabolism Research and Reviews. 15(5). 338–352. 68 indexed citations

17.

Kaufman, Francine, et al.. (1999). Insulin pump therapy in Type 1 pediatric patients: now and into the year 2000. Diabetes/Metabolism Research and Reviews. 15(5). 338–352. 11 indexed citations

18.

Gertner, Joseph M., Francine Kaufman, Sharyne Donfield, et al.. (1994). Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development Study. The Journal of Pediatrics. 124(6). 896–902. 41 indexed citations

19.

Kaufman, Francine, et al.. (1987). Growth hormone secretory patterns in children with short stature. The Journal of Pediatrics. 110(3). 362–368. 55 indexed citations

20.

Kaufman, Francine, et al.. (1986). Urinoma of the fallopian tube in virilizing congenital adrenal hyperplasia. The Journal of Pediatrics. 109(3). 495–496. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact